Ann: Optiscan Webinar Investor Presentation, page-9

Is base on past experience for the movement of the share price, the share price will increase very fast whenever a highly anticipated announcement released. After read through the presentation, that isn't a single information that the shareholder is already known. View n Vivo sales forever in the pipeline, FDA forever delay, The collaboration with Mayo is just another CZM Convivo (how much revenue contribution from there?). There are 7/8 projects run in parallel and how long the cash can last. So is going to be back to 8 cents soon since nothing is really in progress in term of revenue . Sorry, that's how it is going to be.